This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Key CMC Challenges for Innovative Healthcare Products
Published on: Nov 15th, 2022
Have you encountered CMC challenges in the development of your innovative healthcare product? CMC includes all activities vital to product approval: product characteristics, manufacturing methods, and product testing – to ensure product safety, efficiency, and standardization. Moreover, innovative products, such as cell therapy, are classified as ATMPs (Advanced Therapy Medicinal Products) by the FDA. Therefore, they often face specific development challenges, because of their complexity and no defined regulatory framework.
Our CMC team of experts collaborated closely with the client to ensure the project stayed on track and overcame key CMC challenges… Find out more by downloading below!
Download the full resource now
Fill in the form to download the content